{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:50:10Z","timestamp":1793350210673,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41391-025-01001-7","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T04:19:28Z","timestamp":1753244368000},"page":"124-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predicting side-specific extraprostatic extension in prostate cancer using an 18F-DCFPyL PSMA-PET\/CT\u2013based nomogram"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4149-0486","authenticated-orcid":false,"given":"Neeraja","family":"Tillu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7107-0933","authenticated-orcid":false,"given":"Ashutosh","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Kolanukuduru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3420-1578","authenticated-orcid":false,"given":"Yashaswini","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0272-0733","authenticated-orcid":false,"given":"Himanshu","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokhi","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Sur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7946-7145","authenticated-orcid":false,"given":"Reuben","family":"Ben- David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6965-449X","authenticated-orcid":false,"given":"Basil","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asher","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Jodka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Hug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne","family":"Ohayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3143-1893","authenticated-orcid":false,"given":"Susanna","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coskun","family":"Kacagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayak","family":"Wagaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murilo","family":"de Almeida Luz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"1001_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.urology.2014.08.025","volume":"85","author":"MW Ball","year":"2015","unstructured":"Ball MW, Partin AW, Epstein JI. Extent of extraprostatic extension independently influences biochemical recurrence-free survival: evidence for further pT3 subclassification. Urology. 2015;85:161\u20134.","journal-title":"Urology"},{"key":"1001_CR2","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.juro.2013.05.053","volume":"190","author":"MS Eisenberg","year":"2013","unstructured":"Eisenberg MS, Karnes RJ, Kaushik D, Rangel L, Bergstralh EJ, Boorjian SA. Risk stratification of patients with extraprostatic extension and negative lymph nodes at radical prostatectomy: identifying optimal candidates for adjuvant therapy. J Urol. 2013;190:1735\u201341.","journal-title":"J Urol"},{"key":"1001_CR3","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0302-2838(03)00093-9","volume":"43","author":"A Tewari","year":"2003","unstructured":"Tewari A, Peabody JO, Fischer M, Sarle R, Vallancien G, Delmas V, et al. An operative and anatomic study to help in nerve sparing during laparoscopic and robotic radical prostatectomy. Eur Urol. 2003;43:444\u201354.","journal-title":"Eur Urol"},{"key":"1001_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/JU.0000000000002758","volume":"208","author":"JA Eastham","year":"2022","unstructured":"Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, et al. Clinically localized prostate cancer: AUA\/ASTRO Guideline, Part II: principles of active surveillance, principles of surgery, and follow-up. Journal Urol. 2022;208:19\u201325.","journal-title":"Journal Urol"},{"key":"1001_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13244-023-01486-7","volume":"14","author":"M Zhu","year":"2023","unstructured":"Zhu M, Gao J, Han F, Yin L, Zhang L, Yang Y, et al. Diagnostic performance of prediction models for extraprostatic extension in prostate cancer: a systematic review and meta-analysis. Insights Imaging. 2023;14:140.","journal-title":"Insights Imaging"},{"key":"1001_CR6","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41391-023-00734-7","volume":"27","author":"B Fang","year":"2024","unstructured":"Fang B, Zhu Y. Applying prediction models in clinical practice: the importance of fine details. Prostate Cancer Prostatic Dis. 2024;27:584.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1001_CR7","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2967\/jnumed.117.203877","volume":"59","author":"DS O\u2019Keefe","year":"2018","unstructured":"O\u2019Keefe DS, Bacich DJ, Huang SS, Heston WDW. A perspective on the evolving story of PSMA biology, PSMA-based imaging, and endoradiotherapeutic strategies. J Nucl Med. 2018;59:1007\u201313.","journal-title":"J Nucl Med"},{"key":"1001_CR8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/14737140.2022.2081155","volume":"22","author":"AF Voter","year":"2022","unstructured":"Voter AF, Werner RA, Pienta KJ, Gorin MA, Pomper MG, Solnes LB, et al. Piflufolastat F-18 (18 F-DCFPyL) for PSMA PET imaging in prostate cancer. Expert Rev Anticancer Ther. 2022;22:681\u201394.","journal-title":"Expert Rev Anticancer Ther"},{"key":"1001_CR9","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","volume":"50","author":"WP Fendler","year":"2023","unstructured":"Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, et al. PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. 2023;50:1466\u201386.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1001_CR10","doi-asserted-by":"crossref","unstructured":"Hupe MC, Philippi C, Roth D, K\u00fcmpers C, Ribbat-Idel J, Becker F, et al. Expression of prostate-specific membrane antigen (PSMA) on biopsies is an independent risk stratifier of prostate cancer patients at time of initial diagnosis. Front Oncol. 2018;8:623.","DOI":"10.3389\/fonc.2018.00623"},{"key":"1001_CR11","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/bju.14353","volume":"122","author":"A Martini","year":"2018","unstructured":"Martini A, Gupta A, Lewis SC, Cumarasamy S, Haines KG, Briganti A, et al. Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer. BJU Int. 2018;122:1025\u201333.","journal-title":"BJU Int"},{"key":"1001_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol. 2019;76:340\u201351.","journal-title":"Eur Urol"},{"key":"1001_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1148\/radiol.2018181278","volume":"290","author":"S Mehralivand","year":"2019","unstructured":"Mehralivand S, Shih JH, Harmon S, Smith C, Bloom J, Czarniecki M, et al. A grading system for the assessment of risk of extraprostatic extension of prostate cancer at multiparametric MRI. Radiology. 2019;290:709\u201319.","journal-title":"Radiology"},{"key":"1001_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.5858\/2006-130-303-KIIHAR","volume":"130","author":"JR Srigley","year":"2006","unstructured":"Srigley JR. Key issues in handling and reporting radical prostatectomy specimens. Arch Pathol Lab Med. 2006;130:303\u201317.","journal-title":"Arch Pathol Lab Med"},{"key":"1001_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/modpathol.2010.158","volume":"24","author":"C Magi-Galluzzi","year":"2011","unstructured":"Magi-Galluzzi C, Evans AJ, Delahunt B, Epstein JI, Griffiths DF, van der Kwast TH, et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Modern Pathol. 2011;24:26\u201338.","journal-title":"Modern Pathol"},{"key":"1001_CR16","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1464-410X.2011.10565.x","volume":"108","author":"AK Tewari","year":"2011","unstructured":"Tewari AK, Srivastava A, Huang MW, Robinson BD, Shevchuk MM, Durand M, et al. Anatomical grades of nerve sparing: a risk-stratified approach to neural-hammock sparing during robot-assisted radical prostatectomy (RARP). BJU Int. 2011;108:984\u201392.","journal-title":"BJU Int"},{"key":"1001_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0022-5347(17)35415-0","volume":"150","author":"JI Epstein","year":"1993","unstructured":"Epstein JI, Carmichael MJ, Pizovt G, Walsh PC. Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. Journal Urol. 1993;150:135\u201341.","journal-title":"Journal Urol"},{"key":"1001_CR18","doi-asserted-by":"crossref","unstructured":"Ditonno F, Bologna E, Licari LC, Franco A, Cannoletta D, Checcucci E, et al. Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) during robot-assisted radical prostatectomy: a systematic review and meta-analysis of comparative studies. Prostate Cancer Prostatic Dis. 2024. Online ahead of print.","DOI":"10.1038\/s41391-024-00891-3"},{"key":"1001_CR19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","volume":"80","author":"L Emmett","year":"2021","unstructured":"Emmett L, Buteau J, Papa N, Moon D, Thompson J, Roberts MJ, et al. The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study. Eur Urol. 2021;80:682\u20139.","journal-title":"Eur Urol"},{"key":"1001_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s13139-017-0476-7","volume":"51","author":"CAJ von Klot","year":"2017","unstructured":"von Klot CAJ, Merseburger AS, B\u00f6ker A, Schmuck S, Ross TL, Bengel FM, et al. 68Ga-PSMA PET\/CT imaging predicting intraprostatic tumor extent, extracapsular extension and seminal vesicle invasion prior to radical prostatectomy in patients with prostate cancer. Nucl Med Mol Imaging. 2017;51:314\u201322.","journal-title":"Nucl Med Mol Imaging"},{"key":"1001_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2967\/jnumed.121.262398","volume":"63","author":"I Sonni","year":"2022","unstructured":"Sonni I, Felker ER, Lenis AT, Sisk AE, Bahri S, Allen-Auerbach M, et al. Head-to-head comparison of 68 Ga-PSMA-11 PET\/CT and mpMRI with a histopathology gold standard in the detection, intraprostatic localization, and determination of local extension of primary prostate cancer: results from a prospective single-center imaging trial. Journal Nucl Med. 2022;63:847\u201354.","journal-title":"Journal Nucl Med"},{"key":"1001_CR22","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/jamaoncol.2024.3196","volume":"10","author":"N Mookerji","year":"2024","unstructured":"Mookerji N, Pfanner T, Hui A, Huang G, Albers P, Mittal R, et al. Fluorine-18 prostate-specific membrane antigen-1007 PET\/CT vs multiparametric mri for locoregional staging of prostate cancer. JAMA Oncol. 2024;10:1097\u2013103.","journal-title":"JAMA Oncol"},{"key":"1001_CR23","doi-asserted-by":"crossref","unstructured":"Eissa A, Elsherbiny A, Zoeir A, Sandri M, Pirola G, Puliatti S, et al. Reliability of the different versions of Partin tables in predicting extraprostatic extension of prostate cancer: a systematic review and meta-analysis. Minerva Urologica e Nefrologica. 2019;71:457\u201378.","DOI":"10.23736\/S0393-2249.19.03427-1"},{"key":"1001_CR24","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1097\/01.ju.0000158155.33890.e7","volume":"173","author":"MR Cooperberg","year":"2005","unstructured":"Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005;173:1938\u201342.","journal-title":"J Urol"},{"key":"1001_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41391-023-00776-x","volume":"27","author":"A Martini","year":"2024","unstructured":"Martini A, Wever L, Soeterik TFW, Rakauskas A, Fankhauser CD, Grogg JB, et al. An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy. Prostate Cancer Prostatic Dis. 2024;27:520\u20134.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1001_CR26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41391-023-00738-3","volume":"27","author":"JG Heetman","year":"2024","unstructured":"Heetman JG, van der Hoeven EJRJ, Rajwa P, Zattoni F, Kesch C, Shariat S, et al. External validation of nomograms, including MRI features for the prediction of side-specific extraprostatic extension. Prostate Cancer Prostatic Dis. 2024;27:492\u20139.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1001_CR27","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1007\/s00345-022-04191-0","volume":"40","author":"JG Heetman","year":"2022","unstructured":"Heetman JG, Soeterik TFW, Wever L, Meyer AR, Nuininga JE, van Soest RJ, et al. A side-specific nomogram for extraprostatic extension may reduce the positive surgical margin rate in radical prostatectomy. World J Urol. 2022;40:2919\u201324.","journal-title":"World J Urol"},{"key":"1001_CR28","doi-asserted-by":"crossref","unstructured":"Soeterik TFW, Heetman JG, Hermsen R, Wever L, Lavalaye J, Vinken M, et al. The added value of prostate-specific membrane antigen positron emission tomography\/computed tomography to magnetic resonance imaging for local staging of prostate cancer in patients undergoing radical prostatectomy. Eur Urol Oncol. 2025;8:731\u20138.","DOI":"10.1016\/j.euo.2024.11.002"},{"key":"1001_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41391-023-00708-9","volume":"27","author":"F Ditonno","year":"2024","unstructured":"Ditonno F, Franco A, Manfredi C, Veccia A, Valerio M, Bukavina L, et al. Novel non-MRI imaging techniques for primary diagnosis of prostate cancer: micro-ultrasound, contrast-enhanced ultrasound, elastography, multiparametric ultrasound, and PSMA PET\/CT. Prostate Cancer Prostatic Dis. 2024;27:29\u201336.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1001_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/JU.0000000000001698","volume":"206","author":"KJ Pienta","year":"2021","unstructured":"Pienta KJ, Gorin MA, Rowe SP, Carroll PR, Pouliot F, Probst S, et al. A Phase 2\/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET\/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY). J Urol. 2021;206:52\u201361.","journal-title":"J Urol"},{"key":"1001_CR31","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1158\/1078-0432.CCR-20-4573","volume":"27","author":"MJ Morris","year":"2021","unstructured":"Morris MJ, Rowe SP, Gorin MA, Saperstein L, Pouliot F, Josephson D, et al. Diagnostic performance of 18F-DCFPyL-PET\/CT in men with biochemically recurrent prostate cancer: results from the CONDOR phase iii, multicenter study. Clinical Cancer Res. 2021;27:3674\u201382.","journal-title":"Clinical Cancer Res"},{"key":"1001_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-023-01033-x","volume":"13","author":"J Heilinger","year":"2023","unstructured":"Heilinger J, Weindler J, Roth KS, Krapf P, Schom\u00e4cker K, Dietlein M, et al. Threshold for defining PSMA-positivity prior to 177Lu-PSMA therapy: a comparison of [68Ga]Ga-PSMA-11 and [18F]F-DCFPyL in metastatic prostate cancer. EJNMMI Res. 2023;13:83.","journal-title":"EJNMMI Res"},{"key":"1001_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.euo.2022.03.004","volume":"5","author":"L Evangelista","year":"2022","unstructured":"Evangelista L, Maurer T, van der Poel H, Alongi F, Kunikowska J, Laudicella R, et al. [68Ga]Ga-PSMA versus [18F]PSMA positron emission tomography\/computed tomography in the staging of primary and recurrent prostate cancer. a systematic review of the literature. Eur Urol Oncol. 2022;5:273\u201382.","journal-title":"Eur Urol Oncol"},{"key":"1001_CR34","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3892\/ol.2024.14321","volume":"27","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Guo J, Hu L, Yang S, Meng B, Tang Q. Diagnostic performance of 18 F-DCFPyL PET vs. 68 Ga-PSMA PET\/CT in patients with suspected prostate cancer: A systemic review and meta-analysis. Oncol Lett. 2024;27:188.","journal-title":"Oncol Lett"},{"key":"1001_CR35","unstructured":"EAU Guidelines Office, Arnhem, The Netherlands. http:\/\/uroweb.org\/guidelines\/compilations-of-all-guidelines\/ [Internet]. EAU Guidelines. Edn. presented at the EAU Annual Congress Madrid 2025. ISBN 978-94-92671-29-5."}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01001-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01001-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01001-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:05:18Z","timestamp":1771272318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01001-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1001"],"URL":"https:\/\/doi.org\/10.1038\/s41391-025-01001-7","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations, including the principles outlined in the Declaration of Helsinki. Ethical approval for this study was obtained from the Institutional Review Board (IRB) of the Mount Sinai Hospital (Reference Number: MSH IRB 25-00146). The requirement for informed consent was waived by the IRB due to the retrospective nature of the study and the use of de-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}